-
Something wrong with this record ?
The Relationship between Epigenetic Age and Myocardial Infarction/Acute Coronary Syndrome in a Population-Based Nested Case-Control Study
S. Malyutina, O. Chervova, T. Tillmann, V. Maximov, A. Ryabikov, V. Gafarov, JA. Hubacek, H. Pikhart, S. Beck, M. Bobak
Language English Country Switzerland
Document type Journal Article
Grant support
20-15-00371
Russian Scientific Foundation
WT064947
Welcome Trust
WT081081
Welcome Trust
106554/Z/14/Z
Welcome Trust
1RO1AG23522
US National Institute of Aging
NLK
Free Medical Journals
from 2011
PubMed Central
from 2011
Europe PubMed Central
from 2011
ProQuest Central
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2011
PubMed
35055425
DOI
10.3390/jpm12010110
Knihovny.cz E-resources
- Publication type
- Journal Article MeSH
We investigated the relationship between 'epigenetic age' (EA) derived from DNA methylation (DNAm) and myocardial infarction (MI)/acute coronary syndrome (ACS). A random population sample was examined in 2003/2005 (n = 9360, 45-69, the HAPIEE project) and followed up for 15 years. From this cohort, incident MI/ACS (cases, n = 129) and age- and sex-stratified controls (n = 177) were selected for a nested case-control study. Baseline EA (Horvath's, Hannum's, PhenoAge, Skin and Blood) and the differences between EA and chronological age (CA) were calculated (ΔAHr, ΔAHn, ΔAPh, ΔASB). EAs by Horvath's, Hannum's and Skin and Blood were close to CA (median absolute difference, MAD, of 1.08, -1.91 and -2.03 years); PhenoAge had MAD of -9.29 years vs. CA. The adjusted odds ratios (ORs) of MI/ACS per 1-year increments of ΔAHr, ΔAHn, ΔASB and ΔAPh were 1.01 (95% CI 0.95-1.07), 1.01 (95% CI 0.95-1.08), 1.02 (95% CI 0.97-1.06) and 1.01 (0.93-1.09), respectively. When classified into tertiles, only the highest tertile of ΔAPh showed a suggestion of increased risk of MI/ACS with OR 2.09 (1.11-3.94) independent of age and 1.84 (0.99-3.52) in the age- and sex-adjusted model. Metabolic modulation may be the likely mechanism of this association. In conclusion, this case-control study nested in a prospective population-based cohort did not find strong associations between accelerated epigenetic age markers and risk of MI/ACS. Larger cohort studies are needed to re-examine this important research question.
Institute for Global Health University College London London WC1E 6BT UK
Institute of Epidemiology and Health Care University College London London WC1E 6BT UK
UCL Cancer Institute University College London London WC1E 6BT UK
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22010243
- 003
- CZ-PrNML
- 005
- 20220425131751.0
- 007
- ta
- 008
- 220420s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/jpm12010110 $2 doi
- 035 __
- $a (PubMed)35055425
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Malyutina, Sofia $u Research Institute of Internal and Preventive Medicine-Branch of Institute of Cytology and Genetics SB RAS, 630089 Novosibirsk, Russia $1 https://orcid.org/0000000165390466
- 245 14
- $a The Relationship between Epigenetic Age and Myocardial Infarction/Acute Coronary Syndrome in a Population-Based Nested Case-Control Study / $c S. Malyutina, O. Chervova, T. Tillmann, V. Maximov, A. Ryabikov, V. Gafarov, JA. Hubacek, H. Pikhart, S. Beck, M. Bobak
- 520 9_
- $a We investigated the relationship between 'epigenetic age' (EA) derived from DNA methylation (DNAm) and myocardial infarction (MI)/acute coronary syndrome (ACS). A random population sample was examined in 2003/2005 (n = 9360, 45-69, the HAPIEE project) and followed up for 15 years. From this cohort, incident MI/ACS (cases, n = 129) and age- and sex-stratified controls (n = 177) were selected for a nested case-control study. Baseline EA (Horvath's, Hannum's, PhenoAge, Skin and Blood) and the differences between EA and chronological age (CA) were calculated (ΔAHr, ΔAHn, ΔAPh, ΔASB). EAs by Horvath's, Hannum's and Skin and Blood were close to CA (median absolute difference, MAD, of 1.08, -1.91 and -2.03 years); PhenoAge had MAD of -9.29 years vs. CA. The adjusted odds ratios (ORs) of MI/ACS per 1-year increments of ΔAHr, ΔAHn, ΔASB and ΔAPh were 1.01 (95% CI 0.95-1.07), 1.01 (95% CI 0.95-1.08), 1.02 (95% CI 0.97-1.06) and 1.01 (0.93-1.09), respectively. When classified into tertiles, only the highest tertile of ΔAPh showed a suggestion of increased risk of MI/ACS with OR 2.09 (1.11-3.94) independent of age and 1.84 (0.99-3.52) in the age- and sex-adjusted model. Metabolic modulation may be the likely mechanism of this association. In conclusion, this case-control study nested in a prospective population-based cohort did not find strong associations between accelerated epigenetic age markers and risk of MI/ACS. Larger cohort studies are needed to re-examine this important research question.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Chervova, Olga $u UCL Cancer Institute, University College London, London WC1E 6BT, UK $1 https://orcid.org/0000000216719488
- 700 1_
- $a Tillmann, Taavi $u Institute for Global Health, University College London, London WC1E 6BT, UK
- 700 1_
- $a Maximov, Vladimir $u Research Institute of Internal and Preventive Medicine-Branch of Institute of Cytology and Genetics SB RAS, 630089 Novosibirsk, Russia $1 https://orcid.org/0000000271654496
- 700 1_
- $a Ryabikov, Andrew $u Research Institute of Internal and Preventive Medicine-Branch of Institute of Cytology and Genetics SB RAS, 630089 Novosibirsk, Russia
- 700 1_
- $a Gafarov, Valery $u Research Institute of Internal and Preventive Medicine-Branch of Institute of Cytology and Genetics SB RAS, 630089 Novosibirsk, Russia
- 700 1_
- $a Hubacek, Jaroslav A $u Experimental Medicine Centre, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic $1 https://orcid.org/0000000165371353
- 700 1_
- $a Pikhart, Hynek $u Institute of Epidemiology and Health Care, University College London, London WC1E 6BT, UK
- 700 1_
- $a Beck, Stephan $u UCL Cancer Institute, University College London, London WC1E 6BT, UK
- 700 1_
- $a Bobak, Martin $u Institute of Epidemiology and Health Care, University College London, London WC1E 6BT, UK
- 773 0_
- $w MED00203320 $t Journal of personalized medicine $x 2075-4426 $g Roč. 12, č. 1 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35055425 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20220420 $b ABA008
- 991 __
- $a 20220425131749 $b ABA008
- 999 __
- $a ind $b bmc $g 1784531 $s 1161441
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 12 $c 1 $e 20220114 $i 2075-4426 $m Journal of personalized medicine $n J. pers. med. $x MED00203320
- GRA __
- $a 20-15-00371 $p Russian Scientific Foundation
- GRA __
- $a WT064947 $p Welcome Trust
- GRA __
- $a WT081081 $p Welcome Trust
- GRA __
- $a 106554/Z/14/Z $p Welcome Trust
- GRA __
- $a 1RO1AG23522 $p US National Institute of Aging
- LZP __
- $a Pubmed-20220420